Literature DB >> 10899897

Role of monocytes in experimental Staphylococcus aureus endocarditis.

M H Veltrop1, M J Bancsi, R M Bertina, J Thompson.   

Abstract

In the pathogenesis of bacterial endocarditis (BE), the clotting system plays a cardinal role in the formation and maintenance of the endocardial vegetations. The extrinsic pathway is involved in the activation of the coagulation pathway with tissue factor (TF) as the key protein. Staphylococcus aureus is a frequently isolated bacterium from patients with BE. We therefore investigated whether S. aureus can induce TF activity (TFA) on fibrin-adherent monocytes, used as an in vitro model of BE. We also assessed in vivo in rabbits with catheter induced vegetations, the effect of S. aureus infection on vegetational TFA. In vitro experiments showed that adherent S. aureus induced TFA on fibrin-adherent monocytes which was optimal at a bacterium/monocyte ratio of 1 to 1. Monocyte damage occurred when this ratio exceeded 4 to 1 (visually) or 6 to 1 (propidium iodide influx) Consequently, TFA decreased. In vivo S. aureus led to very high bacterial numbers in the vegetations and a significant increase of their weight. However, TFA of infected vegetations was the same as of sterile ones. This may be due to the high bacteria to monocyte ratio as well as bacterium-induced monocyte damage. Teicoplanin treatment of infected rabbits reduced bacterial numbers in the blood and in the vegetations. Two-day treatment resulted in an increase of vegetational TFA, but after four-day treatment vegetational TFA dropped, most probably due to a suboptimal bacterium/monocyte ratio. S. aureus endocarditis in etoposide (Vepesid)-treated rabbits, leading to a selective monocytopenia, caused a rapid death of the animals. In these rabbits no vegetations were found at all. We conclude that, like Streptococcus sanguis and Staphylococcus epidermidis, S. aureus is able to induce TFA in fibrin-adherent blood monocytes. In addition, monocytes have a protective effect during the course of S. aureus endocarditis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899897      PMCID: PMC98446          DOI: 10.1128/IAI.68.8.4818-4821.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  The coagulation cascade: initiation, maintenance, and regulation.

Authors:  E W Davie; K Fujikawa; W Kisiel
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

2.  Antibiotic-induced cell wall fragments of Staphylococcus aureus increase endothelial chemokine secretion and adhesiveness for granulocytes.

Authors:  P van Langevelde; E Ravensbergen; P Grashoff; H Beekhuizen; P H Groeneveld; J T van Dissel
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

3.  Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium.

Authors:  T A Drake; M Pang
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

4.  In vitro development and stability of tolerance to cloxacillin and vancomycin in Staphylococcus aureus.

Authors:  G P Voorn; J Thompson; W H Goessens; W C Schmal-Bauer; P H Broeders; M F Michel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

5.  Procoagulant activity of endocardial vegetations and blood monocytes in rabbits with Streptococcus sanguis endocarditis.

Authors:  A G Buiting; J Thompson; D van der Keur; W C Schmal-Bauer; R M Bertina
Journal:  Thromb Haemost       Date:  1989-11-24       Impact factor: 5.249

6.  Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis.

Authors:  M J Bancsi; J Thompson; R M Bertina
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis.

Authors:  W V Kern; A Engel; S Schieffer; O Prümmer; P Kern
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Role of granulocytes and monocytes in experimental Staphylococcus epidermidis endocarditis.

Authors:  M J Meddens; J Thompson; W C Bauer; J Hermans; R van Furth
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

9.  Influence of monocytes and antibiotic treatment on tissue factor activity of endocardial vegetations in rabbits infected with Streptococcus sanguis.

Authors:  M J Bancsi; M H Veltrop; R M Bertina; J Thompson
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

Review 10.  Early infective endocarditis on prosthetic valves.

Authors:  J Chastre; J L Trouillet
Journal:  Eur Heart J       Date:  1995-04       Impact factor: 29.983

View more
  13 in total

1.  Interleukin-10 regulates the tissue factor activity of monocytes in an in vitro model of bacterial endocarditis.

Authors:  M H Veltrop; J A Langermans; J Thompson; M J Bancsi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells.

Authors:  M H Veltrop; J Thompson; H Beekhuizen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Glucosyltransferases of viridans group streptococci modulate interleukin-6 and adhesion molecule expression in endothelial cells and augment monocytic cell adherence.

Authors:  Chiou-Yueh Yeh; Jen-Yang Chen; Jean-San Chia
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  Peptidoglycan from Staphylococcus aureus induces tissue factor expression and procoagulant activity in human monocytes.

Authors:  Eva Mattsson; Heiko Herwald; Lars Björck; Arne Egesten
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.

Authors:  P Siaperas; A Pefanis; D Iliopoulos; I Katsarolis; A Kyroudi-Voulgari; I Donta; P Karayiannakos; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  EmaA, a potential virulence determinant of Aggregatibacter actinomycetemcomitans in infective endocarditis.

Authors:  Gaoyan Tang; Todd Kitten; Cindy L Munro; George C Wellman; Keith P Mintz
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

7.  The transcriptional programme of human heart valves reveals the natural history of infective endocarditis.

Authors:  Marie Benoit; Franck Thuny; Yannick Le Priol; Hubert Lepidi; Sonia Bastonero; Jean-Paul Casalta; Frédéric Collart; Christian Capo; Didier Raoult; Jean-Louis Mege
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

8.  Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.

Authors:  Ioannis Skiadas; Angelos Pefanis; Apostolos Papalois; Aspasia Kyroudi; Helen Triantafyllidi; Thomas Tsaganos; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

9.  Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms.

Authors:  Takashi Asahara; Masatoshi Takahashi; Koji Nomoto; Hiroo Takayama; Masaharu Onoue; Masami Morotomi; Ryuichiro Tanaka; Teruo Yokokura; Naoya Yamashita
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

Review 10.  Mechanisms of infective endocarditis: pathogen-host interaction and risk states.

Authors:  Karl Werdan; Sebastian Dietz; Bettina Löffler; Silke Niemann; Hasan Bushnaq; Rolf-Edgar Silber; Georg Peters; Ursula Müller-Werdan
Journal:  Nat Rev Cardiol       Date:  2013-11-19       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.